continuous infusion

Type: Keyphrase
Name: continuous infusion
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

New Therapeutic Drug Monitoring Study Findings Reported from University of Udine (Stability of Generic Meropenem Solutions for Administration by...

New Therapeutic Drug Monitoring Study Findings Reported from University of Udine (Stability of Generic Meropenem Solutions for Administration by Continuous Infusion at Normal and Elevated Temperatures)By a News Reporter-Staff News Editor at Drug Week ... [Published 4 Traders - Oct 23 2014]
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

'I see the knife cutting into me... but I feel no pain'

By specifically blocking certain nerves, a doctor can perform surgery on a patient without putting the patient to ‘sleep’.No one knows the true origin of peripheral nerve blocks, but the concept was probably born in 1884 when Dr William Stewart Halsted ... [Published thestar.com.my - Oct 19 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Addition of ATP to midazolam offers enhanced sedation, fewer adverse effects

The journal Anesthesia Progress recently reported results of a study of 10 healthy volunteers who underwent two anesthetic experiments at least two weeks apart. (Photo: www.freeimages.com)NEW YORK, N.Y., USA: The anesthetic drug midazolam is in widespread ... [Published Dental Tribune - Oct 15 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

Methods and systems for providing therapies into the pericardial space

Methods and systems for transvenously accessing the pericardial space via the vascular system and atrial wall, particularly through the superior vena cava and right atrial wall, to deliver a pharmacologic agent, particularly a NO-donor drug, to the heart ... [Published Free Patents Online - Oct 07 2014]
Entities: Infusion, Catheter, distal
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

A 72-Year-Old Man Presenting With Melena and Multiple Falls Becomes Acutely Decompensated

A 72-year-old man was brought to the ED after passing melena for 1 day and multiple falls. The patient had recently undergone a lobectomy for non-small cell lung cancer and was recovering in a rehabilitation facility. He had a history of ischemic stroke ... [Published CHEST - Oct 07 2014]
Entities: Melena, Hemoglobin, Anuria
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

IV Diuretics in Acutely Decompensated Heart Failure

A Randomised Clinical TrialPere Llorens, Òscar Miró, Pablo Herrero, Francisco Javier Martín-Sánchez, Javier Jacob, Amparo Valero, Héctor Alonso, María José Pérez-Durá, Antonio Noval, José Juan Gil-Román, Pedro Zapater, Lucía Llanos, Víctor ... [Published General Medicine eJournal - Oct 07 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Andexanet Alfa Reverses Anti-Clotting Effect of Apixaban in Late-Stage Study

Findings to be presented at AHA meetingA phase III study of andexanet alfa (Portola Pharmaceuticals), a potential universal factor Xa inhibitor antidote and an FDA-designated “breakthrough therapy,” has met its primary and secondary endpoints.Andexanet ... [Published P&T Community - Oct 02 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Positive Results for Factor Xa Inhibitor Antidote

SAN FRANCISCO, CA – A phase 3 study designed to test an antidote to the factor Xa inhibitor class of novel anticoagulants met its primary efficacy end point, according to an announcement from Portola Pharmaceuticals [1] .An intravenous bolus of andexanet ... [Published General Medicine eJournal - Oct 01 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Sector Update: Health Care Stocks Largely Resist Late-Afternoon Decline; Portola Pharma Climbs 16% On Positive Results for Drug

PFE -1.35%ABT -0.94%MRK -0.93%AMGN -1.06%Health care stocks were falling Wednesday with the NYSE Health Care Sector Index declining about 1.0% and shares of health care companies in the S&P 500 also falling about 1.0% as a group.In company news, Portola ... [Published Nasdaq - Oct 01 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Benzodiazepine Sedatives Linked to Higher Rates of Mortality Compared to Propofol

A University of Utah study shows for the first time that continuous infusion benzodiazepines - a class of sedatives that includes lorazepam and midazolam, once considered the standard of care in the ICU - are linked to an increased likelihood of death ... [Published Infrosoft - Sep 30 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Predictors of Arterial Blood Pressure Control During Deliberate Hypotension with Sodium Nitroprusside in Children

BACKGROUND: Sodium nitroprusside (SNP) is used to decrease arterial blood pressure (BP) during certain surgical procedures. There are limited data regarding efficacy of BP control with SNP. There are no data on patient and clinician factors that affect ... [Published Current opinion in allergy and clinical immunology - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Local walkers to raise money for diabetes research

PRESTONSBURG – Over 500 walkers representing local corporations, families, schools, and other organizations are anticipated to come out to Big Sandy Community and Technical College in Prestonsburg, on Saturday, September 27th in support of the Juvenile ... [Published Floyd County Times - Sep 18 2014]

Quotes

According to the news editors, the research concluded: "Degradation of generic meropenem was both time and temperature dependent, and the aqueous solutions were stable for up to 8 hours in the temperature range between 25 degrees C and 35 degrees C, and for up to 5 hours at 40 degrees C ContinuousContinuous infusion of generic meropenem Hospira may be applied in clinical settings with ambient temperature below 35 degrees C, provided that the 5 mg/mL aqueous solution is reconstituted at most after 6-8 hours."
"A further embodiment of the invention is a method for reducing severe, chronic pain in a patient having an implantable pump, comprising: placing ziconotide in a first chamber of a pump implanted in a patient having severe, chronic pain, placing morphine in a second chamber of the pump, and administering the ziconotide and the morphine so that the ziconotide retains at least 80% of the ziconotide activity at 37.degree. C for at least 7 days."

More Content

All (36) | News (34) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
New Therapeutic Drug Monitoring Study Findings ... [Published 4 Traders - Oct 23 2014]
'I see the knife cutting into me... but I feel ... [Published thestar.com.my - Oct 19 2014]
"Methods of Administering Drugs in an Implantab... [Published Pharmacy Choice - Oct 16 2014]
Addition of ATP to midazolam offers enhanced se... [Published Dental Tribune - Oct 15 2014]
Glued IOL implantation can be combined with sil... [Published Orthopedics Today - Oct 10 2014]
Methods and systems for providing therapies int... [Published Free Patents Online - Oct 07 2014]
A 72-Year-Old Man Presenting With Melena and Mu... [Published CHEST - Oct 07 2014]
IV Diuretics in Acutely Decompensated Heart Fai... [Published General Medicine eJournal - Oct 07 2014]
Humanized AXL antibodies [Published PharmCast - Oct 07 2014]
Human medicines European public assessment repo... [Published European Medicines Agency - Oct 06 2014]
Cardiac MRI Catheterization: 10-Year Experience... [Published Theheart.org - Oct 06 2014]
MEDTRONIC : Patent Application Titled "Injectab... [Published 4 Traders - Oct 04 2014]
Andexanet Alfa Reverses Anti-Clotting Effect of... [Published P&T Community - Oct 02 2014]
Positive Results for Factor Xa Inhibitor Antidote [Published General Medicine eJournal - Oct 01 2014]
Sector Update: Health Care Stocks Largely Resis... [Published Nasdaq - Oct 01 2014]
Benzodiazepine Sedatives Linked to Higher Rates... [Published Infrosoft - Sep 30 2014]
Benzodiazepine sedatives linked to higher rates... [Published Health Canal - Sep 30 2014]
Aspirin Versus Heparin for Management of Cerebe... [Published Journal of Bone and Joint Surgery - Sep 30 2014]
Treatment of Advanced Parkinson's Disease [Published General Medicine eJournal - Sep 29 2014]
Push Dose Epinephrine as a Temporizing Measure ... [Published JEMS.com - Sep 26 2014]
PACIRA PHARMACEUTICALS : Patent Issued for Sust... [Published 4 Traders - Sep 24 2014]
Predictors of Arterial Blood Pressure Control D... [Published Current opinion in allergy and clinical immunology - Sep 19 2014]
Immunotherapy in Pediatric Malignancies [Published General Medicine eJournal - Sep 19 2014]
Local walkers to raise money for diabetes research [Published Floyd County Times - Sep 18 2014]
REGENERON PHARMACEUTICALS : Patent Application ... [Published 4 Traders - Sep 18 2014]
Becton Dickinson : Patent Issued for Nighttime ... [Published 4 Traders - Sep 18 2014]
New treatment for Parkinson’s disease [Published Hospital News - Sep 17 2014]
Push Dose Epinehrine as a Temporizing Measure f... [Published JEMS.com - Sep 16 2014]
Addition of ATP to Midazolam Offers Enhanced De... [Published PRWeb - Sep 12 2014]
Agonists of neurotrophin receptors and their us... [Published PharmCast - Aug 14 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Flamel Technologies Announces FDA Approval of V... [Published Marketwire - Breaking News Releases - Jun 30 2014]
LYON, FRANCE--(Marketwired - Jun 30, 2014) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for VAZCULEPT (phenylephrine hydrochloride). VAZCULEP ...
EHR Story for Mother's Day 2014: Even The Forme... [Published Health Care Renewal - May 09 2014]
[Note to the humorless:  this post is satirical to make a very serious point, a point too often ignored by those who know better.  If you don't like satire, don't read it.]I've been critiqued for posting in too gloomy a manner for some's taste, even those ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.